A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT01484587 · COMPLETED
Trial details
- NCT number
- NCT01484587
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-22
- Primary completion
- 2013-04-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.